"McKinsey Settles Opioid Claims with $78M Payout to Insurers and Benefit Plans"

Consulting firm McKinsey & Co. has agreed to a $78 million settlement with insurers and healthcare funds over allegations that its work with Purdue Pharma and other drug companies contributed to the opioid crisis. The settlement, pending judicial approval, will establish a fund to reimburse prescription opioid costs and addiction treatments. This follows McKinsey's previous settlements totaling nearly $830 million with U.S. states, territories, and local entities. Despite the settlements, McKinsey maintains that its past work was lawful and ceased advising on opioid-related business in 2019.